ProPhase Labs, Inc. PRPH
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -43.52% | -41.97% | -35.82% | -42.39% | -64.46% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -43.52% | -41.97% | -35.82% | -42.39% | -64.46% |
| Cost of Revenue | -38.10% | -56.24% | -57.21% | -65.62% | -74.42% |
| Gross Profit | -60.98% | 135.09% | 1,022.67% | 132.30% | 240.36% |
| SG&A Expenses | -49.79% | -48.08% | -48.99% | 5.56% | 6.13% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -48.81% | -49.68% | -50.68% | -16.40% | -23.75% |
| Operating Income | 49.76% | 50.99% | 53.28% | 9.42% | 4.17% |
| Income Before Tax | 36.79% | 41.70% | 44.75% | 1.70% | -1.67% |
| Income Tax Expenses | -95.27% | -85.92% | -100.00% | 247.72% | 236.30% |
| Earnings from Continuing Operations | 52.52% | 50.57% | 52.78% | -100.63% | -91.68% |
| Earnings from Discontinued Operations | -100.00% | -100.00% | 325.16% | 357.39% | 535.78% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 45.38% | 44.21% | 72.37% | -50.25% | -57.55% |
| EBIT | 49.76% | 50.99% | 53.28% | 9.42% | 4.17% |
| EBITDA | 53.58% | 55.67% | 59.27% | 7.51% | 1.78% |
| EPS Basic | 85.15% | 82.46% | 92.12% | -5.95% | -21.69% |
| Normalized Basic EPS | 80.03% | 81.90% | 80.37% | 40.16% | 28.80% |
| EPS Diluted | 85.17% | 82.48% | 92.11% | -5.53% | -21.10% |
| Normalized Diluted EPS | 80.03% | 81.90% | 80.37% | 40.16% | 28.80% |
| Average Basic Shares Outstanding | 338.98% | 339.82% | 324.38% | 92.11% | 66.06% |
| Average Diluted Shares Outstanding | 338.98% | 339.82% | 324.38% | 92.11% | 66.06% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |